Mimotopes selected with neutralizing antibodies against multiple subtypes of influenza A
- Equal contributors
1 Pediatric Liver Disease Research Laboratory, Institute of Infectious Diseases, Beijing 302 Hospital, Beijing, China
2 Department of Nuclear Medicine, PUMC Hospital, PUMC & CAMS, Beijing, China
3 Institute of Disease Control and Prevention, Academy of Military Medical Sciences, Beijing, China
4 Liver Center, Beijing Ditan Hospital, Capital Medical University, Beijing, China
Virology Journal 2011, 8:542 doi:10.1186/1743-422X-8-542Published: 15 December 2011
The mimotopes of viruses are considered as the good targets for vaccine design. We prepared mimotopes against multiple subtypes of influenza A and evaluate their immune responses in flu virus challenged Balb/c mice.
The mimotopes of influenza A including pandemic H1N1, H3N2, H2N2 and H1N1 swine-origin influenza virus were screened by peptide phage display libraries, respectively. These mimotopes were engineered in one protein as multi- epitopes in Escherichia coli (E. coli) and purified. Balb/c mice were immunized using the multi-mimotopes protein and specific antibody responses were analyzed using hemagglutination inhibition (HI) assay and enzyme-linked immunosorbent assay (ELISA). The lung inflammation level was evaluated by hematoxylin and eosin (HE).
Linear heptopeptide and dodecapeptide mimotopes were obtained for these influenza virus. The recombinant multi-mimotopes protein was a 73 kDa fusion protein. Comparing immunized infected groups with unimmunized infected subsets, significant differences were observed in the body weight loss and survival rate. The antiserum contained higher HI Ab titer against H1N1 virus and the lung inflammation level were significantly decreased in immunized infected groups.
Phage-displayed mimotopes against multiple subtypes of influenza A were accessible to the mouse immune system and triggered a humoral response to above virus.